Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
Among adults with type 1 diabetes and obesity, tirzepatide was superior to placebo for weight loss over 12 weeks.
Authors
- Jerry Richard Greenfield (ORCID: https://orcid.org/0000-0002-0866-0973)
- Jennifer Snaith (ORCID: https://orcid.org/0000-0001-8559-8387)
- Dorit Samocha‐Bonet (ORCID: https://orcid.org/0000-0001-9422-7852)
- Ruth Frampton (ORCID: https://orcid.org/0000-0003-4825-5654)
Institutions
- Garvan Institute of Medical Research (AU)
- Canberra Hospital (AU)
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- St Vincent's Clinic (AU)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-11-20
- DOI
- https://doi.org/10.2337/dc25-2379
- Citations
- 5
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 6.47
Funders
- St. Vincent's Clinic Foundation
- Australian Diabetes Society
- University of New South Wales